|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.670 USD | +11.33% |
|
-.--% | +221.15% |
| 01/06 | Revium Rx. Announces CFO Changes, Effective May 27, 2026 | CI |
| 15/05 | Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
Non-Durable Goods Distribution | ||||
Net Income | -12.13L | -7L | -35.05L | -1.34Cr |
D&A | 2T | 2T | 4T | 6T |
Operating Income | -11.91L | -7L | -35.68L | -1.31Cr |
EBT | -12.13L | -7L | -35.05L | -1.31Cr |
CAPEX | -2T | -1T | -3T | -7T |
Income Tax Expense | - | - | - | 4L |
Interest Expense | -22T | -3T | -2T | - |
Total Assets | 5L | 56.3L | 2.03Cr | 82.96L |
Geographical Revenue Distribution History
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
Operating Income | -11.91L | -7L | -35.68L | -1.31Cr |
Net Income | -12.13L | -7L | -35.05L | -1.34Cr |
EBT | -12.13L | -7L | -35.05L | -1.31Cr |
CAPEX | -2T | -1T | -3T | -7T |
D&A | 2T | 2T | 4T | 6T |
Income Tax Expense | - | - | - | 4L |
Interest Expense | -22T | -3T | -2T | - |
Total Assets | 5L | 56.3L | 2.03Cr | 82.96L |
- Stock Market
- Stocks
- RVRC Stock
- Financials Revium Rx.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
